Medifast (MED) Other Non-Current Assets (2010 - 2026)

Medifast's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $6.9 million for Q1 2026.

• Quarterly Other Non-Current Assets fell 21.47% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (down 21.47% YoY) and the FY2025 annual result came in at $7.8 million, down 19.02% from the prior year.
• Other Non-Current Assets was $6.9 million for Q1 2026 at Medifast, down from $7.8 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $15.8 million in Q3 2023 and bottomed at $6.9 million in Q1 2026.
• A 5-year average of $11.4 million and a median of $12.0 million in 2022 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 286.44% — and 2025, when it slumped 36.07%.
• Medifast's Other Non-Current Assets stood at $12.5 million in 2022, then increased by 17.61% to $14.6 million in 2023, then slumped by 34.01% to $9.7 million in 2024, then fell by 19.02% to $7.8 million in 2025, then slipped by 12.47% to $6.9 million in 2026.
• Business Quant data shows MED's Other Non-Current Assets at $6.9 million in Q1 2026, $7.8 million in Q4 2025, and $7.0 million in Q3 2025.